REG
MAR
Eevia Board Terminates Process for Reverse Takeover
Further to the press release Eevia made on December 2 about Eevia Health Plc ("Eevia" or "The Company") receiving a proposal for a reverse takeover (RTO) from Stemtech Corporatio...
Eevia Health Plc receives a MSEK 1,8 (KUSD 169) sales order
Eevia Health ("Eevia" or "The Company") received a MSEK 1,849 / KUSD 169 blanket sales order for the elderberry extract Feno-Sambucus™ 7 ORGANIC from a distributor in the US.
REG
MAR
Eevia is subject to a possible reverse takeover
Eevia Health Plc ("Eevia" or "The Company") received a proposal for a reverse takeover (RTO) from Stemtech Corporation[1] ("Stemtech"), a US company, on November 10. The proposal...
REG
MAR
Eevia Health Plc: Eevia Health Plc Interim Report Q3 - 2024
The Board and CEO of Eevia Health Plc present the Interim financial report for quarter 3, 2024.
Financial developments and significant events in the third quarter of 2024:
· Net...
Eevia revises financial targets
The new Board of Eevia Health Plc ("Eevia" or "The Company") has approved a new strategic business plan for 2025 - 2026. The new strategy is also a turnaround plan for the Compan...
REG
Eevia revises date for release of Interim report Q3-2024
Eevia Health Plc ("Eevia" or "The Company") will publish its Interim report for the third quarter on November 29 due to the onboarding of a new Board and one large unforeseen urg...
REG
Communique from the EXTRAORDINARY General Meeting OF SHAREHOLDERS in Eevia Health Plc
The Extraordinary General Meeting of Shareholders of Eevia Health Plc, corp. Reg. No 2825194-4 (the "Company") was held on November 4, 2024, in Seinäjoki, Finland, whereby the sh...
Eevia goes neck and neck with the market leader in a new whitepaper
Eevia Health Plc ("Eevia" or "The Company") has published a follow-up whitepaper of its research article published on May 2. The whitepaper showcases one of its hero products, Fe...
REG
UPDATE: Dr. Diane Clayton suggested as new Board member in Eevia Health
A press release on October 7 (Correction on November 14) notified the shareholders of Eevia Health Plc ("Eevia" or "The Company") of an Extraordinary General Meeting to be held o...
Eevia Health Plc receives a 587 KSEK (51 KEUR) sales order for a Bilberry extract product
Eevia Health Plc ("Eevia" or "The Company") has received a 51 KEUR sales order from a European nutraceutical brand owner.
REG
MAR
CORRECTION: Eevia Health enters negotiations for a significant sales contract
The correction is related to a press release on 12.01.2024 where Eevia Health Plc ("Eevia" or the "Company") announced it had entered negotiations with a European food manufactur...
Eevia Health is presenting at the Nutrition Investor event in Las Vegas
Eevia Health Plc ("Eevia" or the "Company") will present at the Nutrition Capital Network's Ingredient Technology Investor Meeting today in Mandalay Bay, Las Vegas. The presentat...
Eevia Health receives multiple sales orders for c. KSEK 702 (KEUR 61)
Eevia Health Plc ("Eevia" or "The Company") received several sales orders for extracts totaling KEUR 61 from various European customers.
REG
CORRECTION: Notice to the Extraordinary General Meeting of Eevia Health Abp
The notice has the following corrections (in bold): The Record date is October 23 and not October 24. The deadline for nominee registered shares is October 30 not October 29. Sha...
REG
Notice to the Extraordinary General Meeting of Eevia Health Ab
This notice is given to the shareholders of Eevia Health Abp (Plc) for an Extraordinary General Meeting to be held on November 4, 2024, at noon (Finnish time GMT +3) at the main...
REG
MAR
Eevia decides to initiate a strategic reorientation and company turnaround
The Board of Directors of Eevia Health Plc ("Eevia" or "The Company") has today decided to initiate a turnaround plan and a strategic reorientation towards capturing significant...
REG
MAR
Eevia Health's Board of Directors has resolved a directed share issue of 2,700,107 shares
The Board of Directors of Eevia Health Oyj (publ) ("Eevia" or the "Company") has resolved a directed new issue of 2,700,107 shares at a subscription price of EUR 0,05 per share (...
REG
Eevia Health receives multiple sales orders for c. Ksek 635 (KEUR 56)
Eevia Health PLC ("Eevia" or "The Company") received several sales orders for extracts totaling KEUR 56 from various European and Asian customers.
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.
Webbplats
eeviahealth.com/investors
Handelsinformation
Kurs ()
Förändring ()
